SlideShare a Scribd company logo
Dr. Chetan Chaudhari
DNB Resident
Department of Paediatrics
HINDUHRIDAYSAMRAT BALASAHEB THACKERAY
MEDICAL COLLEGE (HBTMC) & DR.R.N.COOPER
MUNICIPAL GENERAL HOSPITAL, MUMBAI
Date- 28st October 2020
 On 31st July 2020
 Roshani Gupta, 11 yrs old Female Child
 Admitted at Dr.R.N.Cooper Hospital for the first time
 Brought by : Mother (Informant Reliable)
 Chief complaints:
Fever since 4 days
Body ache, Headache since 3 days
Abdominal pain since 3 days
Decreased oral intake since 3 days
Difficulty in breathing since 1 day
Clinical Scenario

Short History
 Fever - 4 Days back, undocumented fever, insidious onset, mod-high grade,
intermittent, no diurnal variations, relieved on oral medications. No chills or
rigors. Normal inter febrile.
followed by myalgia, Headache
 Next day- persistence of above complaints +
Abdominal pain, Decreased oral intake
Decreased Urine Output
 Difficulty in breathing – 1 Day prior, fast and labored breathing,
progressive
 Relevant H/O wading in rain water a week ago,
 Normal Birth History, completely immunized, developmentally Normal,
averagely built well nourished child
History of present illness

DOA 1
Day 5 illness
Conscious, Alert, GCS 15, in cardiorespiratory distress
with vitals:
• Temp: 37 C HR: 120 bpm RR: 60 bpm
• SPO2: 90% off O2 BP: 110/70 mmHg (50th-90th)
RS:
• Tachypnea+, Symmetrical expansion
• B/L AE reduced, B/L crepts +
• +Intercostal retraction + Subcostal retraction
• no local tenderness,
• On O2 CPAP 96% with +RD +WOB
Course in Ward

On Examination
• CVS: Normal precordium,
Apex beat at left 5th ICS MCL, (-) murmur,
Tachycardia+
(-) thrills, (-) palpable P2; normally split S2;
• Abdo: no scars, soft, no guarding/rigidity
bowel sounds present,
Liver non palpable, span 8 cm, Non tender
Course in Ward

On Examination
CNS: Conscious, oriented, follows commands
GCS 15 (E4V5M6)
Rest neurologic exam were unremarkable
By 6 Hours
of
Admission
• Diagnostics sent:
ABG, CBC with DLC, PS, RMAT, CRP, BUN, S.Creat, S.
Electrolytes, AST, ALT, PT APTT, blood CS, U/RM,
Dengue test, Leptospira test, CXR PA, Covid-19 swab
• Tachypnea+, ++ WOB, Significant distress with
impending Respiratory failure,
• ARDS
• Hypotensive
• Intubated, inotropes added, Upgraded AB
• Pt. was Transferred to PICU
Course in Ward

Under Evaluation
Any thoughts ?? Any Questions ??

Any thoughts ?? Lab Reports!!

• Lepto IgM + Lepto ELISA +
• HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35
• BUN-17.8, Creat-0.9, SGOT-50,SGPT-36
• Na+135, K+3.8, Cl-99
• ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4
DOA 1
Day 5 illness
Any thoughts ?? Lab Reports!!

• Lepto IgM + Lepto ELISA +
• HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35
• BUN-17.8, Creat-0.9, SGOT-50,SGPT-36
• Na+135, K+3.8, Cl-99
• ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4
DOA 1
Day 5 illness
By 4-5 Days
of
Admission
On Mech. Ventilation,
Over next few days Child had developed
Oligouria, U/O ~ 0.7ml/kg/hr,
Profuse pulmonary bleed,
High grade Fever, continued RD+
GCS – 11/15
Any thoughts ?? Lab Reports!!

• HB- 5.7, TLC- 22400, PLT- 81000, INR- 2.38
• BUN-112, Creat- 4.9, SGOT-7210,SGPT-4894
• Na+ 158, K+ 4.3, Cl-120
• MRI Brain- fronto-parietal micro haemorrhages,
Chronic subdural hygroma
By
DOA 5
Day 10 illness
Any thoughts ?? Lab Reports!!

• Lepto IgM + Lepto ELISA +
• HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35
• BUN-17.8, Creat-0.9, SGOT-50,SGPT-36
• Na+135, K+3.8, Cl-99
• ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4
DOA 1
Day 5 illness
• HB- 5.7, TLC- 22400, PLT- 81000, INR- 2.38
• BUN-112, Creat- 4.9, SGOT-7210,SGPT-4894
• Na+ 158, K+ 4.3, Cl-120
• MRI Brain- fronto-parietal micro haemorrhages,
Chronic subdural hygroma
By
DOA 5
Day 10 illness
Diagnosis

Leptospirosis with Multi Organ Dysfunction
(ARDS with Pulmonary hemorrhage with Acute
Liver Failure, Acute Kidney Failure, Hypernatremia)
with Multiple intracranial hemorrhages with Bed sores
treated for above diagnosis (3 PRBC, 3FFP, 3PLT, Inotropes, IV
Steroids, Higher Antibiotics, Antifungal, Sedation,
Antiepileptic, Neurotropic Proteins)
25 Days of Hospitalization
Dr. Chetan Chaudhari
DNB Resident
Department of Paediatrics
HINDUHRIDAYSAMRAT BALASAHEB THACKERAY
MEDICAL COLLEGE (HBTMC) & DR.R.N.COOPER
MUNICIPAL GENERAL HOSPITAL, MUMBAI
Overview
 Common & widespread zoonotic disease in the world in
tropical and subtropical countries
 Historically known as Weil’sdisease
(Described in 1885 by Adolf Weil)
 One of the emerging infectious diseases since the late 1990s
Recent large outbreaks in Asia, Central & South America
 Hosts - rats, dogs, cattle and pigs. Reservoir: rodents
 Leptospires survive for days to weeks in water and moist soil
 Transmission:
Exposure to water or soil contaminated with rat urine
Exposure to contaminated floodwaters
High-risk occupations
EPIDEMIOLOGY

 Patterns of transmission Epidemic / Endemic / Sporadic
 In India, only sporadic cases being recorded.
 Urban leptospirosis - reported from Mumbai & Chennai
Last Outbreak reported was in Mumbai in 2015
 Rural leptospirosis - Gujarat, Kerala & Andaman
 Leptospirosis is endemic in
 Kerala
 Tamil Nadu
 Gujarat
 Karnataka
 Maharashtra
 Annual incidence (WHO) – 0.1 to 1 per 100 000 per year
 Estimated case-fatality rates ranges from <5% - 30%
 SpirocheteLeptospira –
22 species,
10 pathogenic species
L. interrogans,
L.icterohaemorrhagiae,
L.copenhageni
 All species are
morphologicallyidentical
Obligate
Aerobic
Motile
Tightly & regularly coiled,
MORPHOLOGY

Electron Microscopy
Infects mucosa (oral, nasal or conjunctival) or through
abraded skin or ingestion of contaminated water
Proliferate in bloodstream and disseminate
hematogenously
Development of antibodies(5-7 days)
Organisms disappear from blood & CSF but remain
localized in tissues, organs including kidneys, brain,
liver, lung, heart
Pathogenesis
Loss of fluids into the third space
Hypovolaemic shock and vascular collapse
Vascular Endothelial damage - produces endotoxin
Attach onto the endothelial cells
Capillary endothelial necrosis and lymphocytic infiltration
Vasculitis and leakage : petechiae, intra parenchymal
bleeding and bleeding along serosa and mucosa
Excreted in urine
Interstitial Nephiritis, Tubular Injury
Penetrate basement membrane of PCT
Adhere to proximal tubule epithelial cells
Traverse interstitial spaces of kidney
Brain – Aseptic meningitis, meningoencephalitis
Eyes - Uveitis
Lungs – involvement due to hemorrhage
(not inflammation)
Liver – Centrilobular Necrosis(usually not extensive)
Cholecystitis, Pancreatitis
Heart – Myocarditis, Skeletal Muscles – necrosis
 Incubation period - 2 to 30 days (mean: 15 days)
 Spectrum of disease - Asymptomatic (90%)
Severe disease - (10%) with MODS & Death
 Onset is abrupt & follows classically described biphasic course
 Initial or Septicemic phase : 3-7 days
leptospira in blood, CSF
 Immune or leptospiruric phase :
leptospira in urine
appearance of circulating IgM antibody,
disappearance of organisms from the blood and CSF
signs and symptoms with localization of leptospira in tissues
Clinical course

Clinical course & Clinical Menifestations
 fever - Abrupt onset with flulike signs with shaking chills, lethargy, severe
headache, malaise, generalized lymphadenopathy
 Myalgia - severe debilitating myalgia most prominent in the lower extremities,
lumbosacral spine, and abdomen (increase in Sr CPK level)
 Cunjunctival suffusion ( but no chemosis and purulent exudate)
 Rash - transient (<24 hr) erythematous maculopapular, urticarial, petechial,
purpuric or desquamating rash
 Aseptic meningitis - Immune phase
(80% of infected children -abnormal CSF profiles,
only 50% - clinical meningeal manifestations)
pleocytosis with polymorphonuclear leukocytosis,
normal or slightly elevated protein levels, and normal glucose
CNS symptoms resolve spontaneously within 1 wk
 Uveitis selflimited - unilateral or bilateral
Anicteric Leptospirosis
conjunctival suffusion
petechial rash
 Weil syndrome is a severe Severe form of leptospirosis
more common in adults (>30 yr)
 characterized by jaundice
 Initial phase manifestations are similar to anicteric leptospirosis
 Immune phase - Jaundice, Acute renal dysfunction & Thrombocytopenia
 Fulminant cases – menifest with
Pulmonary hemorrhage (morecommonly)
Cardiovascular collapse
Hepatic involvement
Renal dysfunction
Multisystem involvementoccurs
Icteric Leptospirosis
(Weil’s Syndrome)
 Jaundice 4 - 7 day (direct & indirect hyperbilirubinemia)
 right upper quadrant pain, tender hepatomegaly
 modestly elevated serum levels of hepatic enzymes
(<5 times the upper limit)
 cholestasis with hepatocellular necrosis
 Liver function usually returns to normal after recovery
 Hepatic encephalopathy or death due to hepatic failure is rare
 Splenomegaly in a minority of patients
Hepatic involvement

 Acute kidney failure occurs in 16–40% of cases (most severe complication)
 can occur after several days of illness (by 4th day or by 2nd wk)
 Urine analysis - hematuria, pyuria, proteinuria
 nonoliguric with K+ wasting, but may become oliguric
 acute tubular necrosis (ATN) and interstitial nephritis
 Azotemia - features of uremia like breathlessness, convulsion, delirium and
altered level of consciousness in very severe cases
 Severe acute failure cases- may require vasopressor support and hemodialysis,
complete recovery occurs by the end of the 4th week, usually no residual renal
dysfunction
Renal involvement

Immunohistochemical demonstration of leptospira in kidney tissue
 Mild illness - only cough, chest pain and blood tinged sputum
 Severe cases - hemoptysis, rapidly increasing breathlessness which may lead to
respiratory failure and death.
 toxin-mediated capillary vasculitis OR immune mediated
Capillary injury in the lungs >> leakage >> inflammatory reaction
Pulmonary oedema >> fibrin depositions and proliferative fibroblastic reactions
>> intra-alveolar haemorrhage >> acute respiratory distress syndrome (ARDS)
Severe Pulmonary Form of Leptospirosis (SPFL) –
intra-alveolar haemorrhage >> acute respiratory failure >> death
 Death - within hours to 2 days due to pulmonary hemorrhage and severe
respiratory distress.
 Pulmonary haemorrhage syndrome >50% mortality rate
Pulmonary involvement

 Hemorrhagic pneumonitis
with interstitial and
intra alveolar hemorrhage
surrounded by
focal capillary injury
are common pathologic changes.
 O/E – Tachypnea,
crepitation in the basal region,
which rapidly spread upwards
to middle and upper lobes.
Pulmonary involvement

Alveolar infiltrates are visible on CXR
(basal and mid zone)
 Abnormal ECG in 90% of cases. but congestive heart failure is uncommon
 Myocarditis - Segmental depression and T wave inversion may be present in
some patients.
 Shock – Echocardiography reveals normal systolic function of left ventricle
hypotension is due to either dehydration or peripheral vasodilatation
 Arrhythmias - palpitations, syncope and irregular pulse.
Supraventricular tachyarrhythmia
A.V. blocks of various degrees
Ventricular tachycardia infrequently
Cardiovascular system involvement

 CNS - commonly present as meningitis.
Aseptic Meningitis
Headache, irritability, seizures & coma can occur.
Encephalitis, focal deficits, spasticity, paralysis, nystagmus,
peripheral neuropathies, nerve palsies
 Transient thrombocytopenia in >50% of cases.
Rarely, hemorrhagic manifestations occur,
epistaxis, hemoptysis
gastrointestinal, and adrenal hemorrhage
bleeding manifestations in leptospirosis resolve in 2-3 days
 Anterior uveal tract inflammation - Uveitis , iridocyclitis & rarely
chorioretinitis
Other Menifestations

 Suspected: Acute febrile illness with headache, myalgia and prostration
associated with a history of exposure to infected animals or an environment
contaminated with animal urine with one or more of the following –
Calf muscle tenderness
Conjunctival suffusion
Anuria or oliguria and/or proteinuria
Jaundice
Hemorrhagic manifestations (intestines, lung)
Meningeal irritation
Nausea, Vomiting, Abdominal pain, Diarrhoea.
 Probable: Suspected case with positive presumptive laboratory diagnosis.
 Confirmed: Suspect/Probable case with confirmatory laboratory test.
Recommended case definition

Presumptive diagnosis
 A positive result in IgM based immune assays, slide agglutination test or latex
agglutination test or immuno-chromatographic test.
 A Microscopic Agglutination Test (MAT) titre of 100/200/400 or above in single
sample based on endemicity.
 Demonstration of leptospires directly or by staining methods
Confirmatory diagnosis
 Isolation of leptospires from clinical specimen
 Four fold or greater rise in the MAT titer between acute and convalescent
phase serum specimens run in parallel.
 Positive by any two different type of rapid test.
 PCR test.
Criteria for Diagnosis

 High index of suspicion - exposure history & manifestations
 “In endemic area all cases of fever with myalgia and conjunctival suffusion
should be considered as suspected cases of leptospirosis.”
 Biochemical, hematological and urinalysis may suggest
but are not specific for diagnosis
 The disease is usually diagnosed by –
Serological tests – MAT
Molecular- DNA PCR
Rapid tests – ELISA
Latex agglutination test
Dipstick tests ( Lepto dipstick, Lepto Tek)
Lepto Tek, Dri-Dot test
Indirect hemagglutination
Macroscopic slide agglutination test (MSAT)
Diagnosis

Gold standard diagnostic method is the Microscopic Agglutination Test
 Rapid tests - simple, more sensitive and become positive earlier than MAT
(5-6th day) as they detect specific IgM antibodies
 Culture - Leptospires can be cultured from blood and CSF during first 7-10
days, but takes 2-4 weeks to bepositive
Dark field microscopy showing Leptospira spp.
Microscopic Agglutination Test(MAT)
 Sensitivity 92% Specificity 95%
 MAT has a very limited availability
 Negative in the first 7–10 days of onset on infection
Treatment
 Prompt initiation of antibiotic therapy shortens the course
and prevents progression.
 Prompt triage of High risk patients & early supportive T/t
 Mild leptospirosis resolves without any treatment.
 Severe disease - empirically broad- spectrum antibiotics before
confirmation
 Hypotension to be managed by fluids and vasopressors
 Transfusion of blood and blood products
 Specific Treatment of various organ system failure – Cardiovascular
Pulmonary
Renal
Hepatic
 Mild disease - Oral Doxycycline, Amoxicillin, and Ampicillin
 Penicillin G
(Inj. Crystalline penicillin 2–4 lacs IU/kg/day divided every 4-6 hr IV for 7 days)
 Doxycycline (in children ≥8 yr of age)
a short (<2 wk) course of doxycycline may be safe in children >2 yr of age
Doxycycline 2 mg/kg/day divided in 2 doses (max 100 mg twice daily)
 Cefotaxime, Ceftriaxone, and Azithromycin
have demonstrated equivalent effectiveness with doxycycline
Children< 8 years:
 Amoxycillin/ Ampicillin 30-50 mg/kg/day in divided doses for 7 days
 Inj. Crystalline penicillin 2–4 lacs IU/kg/ day for 7 days.
 Ceftriaxone 50-75 IV mg/kg/day for 7 days
 Cefotaxime 50-100 IV mg/kg/day for 7 days
 Erythromycin OR Azithromycin may be given
Antibiotics

 Transfusion of blood and blood products
 Intensive immunosuppression - IV methylprednisolone
 IV Methylprednisone f/b oral prednisolone for 7 days
(Dose: 1 gram methylprednisone IV for first 3 days
f/b oral prednisolone 1 mg/kg for 7 days.)
reduced the need for ventilator support
Steroids effective if given within first 24 hours of onset of pulmonary symptoms
 Timely initiation of mechanical ventilation with PEEP and high FiO2
 Hypoxemia in leptospirosis with pulmonary hemorrhage - difficult to treat
inspite of maximal mechanical ventilation.
 ECMO - cardiopulmonary support
minimizes the damage by mechanical ventilation requiring high
FiO2, high tidal volumes and high airway pressures
Specific T/t of Organ System Failure

Pulmonary hemorrhage
 Management of fluids and electrolytes
 Management of AKI - Diuretic therapy
 Acute interstitial nephritis - short course corticosteroids
 Renal replacement therapy
 Indications for acute renal replacement therapy or dialysis -
Uremic Symptoms
encephalopathy
Serum creatinine > 3mg/dL
Severe hyperkalaemia unresponsive to traditional treatment
Serum K > 5.5 meqs/L in an oliguric patient
Severe volume overload
ARDS, Pulmonary hemorrhage pH <7.2
Fluid overload
 Hemodialysis is preferred over peritoneal dialysis
Specific T/t of Organ System Failure

Renal Dysfunction & Renal Replacement Therapy
Prognosis

 High mortality in severe disease,
 Pulmonary haemorrhage >50% mortality rate
 Poor prognostic indicators - pulmonary involvement, elevated
creatinine, oliguria and thrombocytopenia
 Liver dysfunction has not been confirmed to be an independent risk
factor for death
 No permanent sequelae or progressive organ dysfunction after
resolution
“Patients with multiple organ involvement to be referred to tertiary care centre”
 No vaccine availablecurrently
1. Personal protection
General sanitation measures, Rodents Control
Avoidance of swimming in contaminated places
Avoid of direct and indirect human contact with animal urine
Use rubber shoes and gloves in water logged areas
2. Chemoprophylaxis
During the peak transmission season
Doxycycline 200 mg, once a week, for six weeks
(never to be extended for more than eight weeks)
Alternative-Azithromycin 10 mg/kg single dose (max 500 mg)
PREVENTION

 Adequate history of exposure is most important in diagnosis
 Possibility of leptospirosis to be kept in d/d of
icteric illness
acute flulike febrile illnesses.
 Prompt treatment can prevent life threatening complications
 Dialysis for acute kidney injury (AKI) and ventilatory support for
respiratory failure would definitely reduce mortality.
 Health education, sanitation measures and awareness for prevention
Take Home Message

Leptospirosis in child in mumbai
Leptospirosis in child in mumbai

More Related Content

What's hot

Pyrexia (Fever) of Unknown Origin by DR KD DELE
Pyrexia (Fever) of Unknown Origin by DR KD DELEPyrexia (Fever) of Unknown Origin by DR KD DELE
Pyrexia (Fever) of Unknown Origin by DR KD DELE
Kemi Dele-Ijagbulu
 
Probable dengue
Probable dengueProbable dengue
Probable dengue
Soroy Lardo
 
Pyrexia of unknown origin (puo)
Pyrexia of unknown origin (puo)Pyrexia of unknown origin (puo)
Pyrexia of unknown origin (puo)Mohd Hanafi
 
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
Veerabhadra Kasyapa J
 
Pyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed HussienPyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed Hussien
Kafrelsheiekh University
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
Ranjithkumar Kondapaka
 
PUO
PUOPUO
Adult Onset Still's Disease
 Adult Onset Still's Disease Adult Onset Still's Disease
Adult Onset Still's Disease
Apollo Hospitals
 
Fever of Unknown Origin
Fever of Unknown OriginFever of Unknown Origin
Fever of Unknown Origin
Sindhu Y
 
Fever unknown Origin
Fever unknown OriginFever unknown Origin
Fever unknown Origin
Budi Riyanto
 
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
Suprakash Das
 
Janudice
JanudiceJanudice
Janudice
Zain Khan
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
Al Tarique
 
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACHFEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
Dr ABU SURAIH SAKHRI
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
Dr-mahmoud Desoky
 
Protocol for fever
Protocol for feverProtocol for fever
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
shayanfatima
 

What's hot (20)

Pyrexia (Fever) of Unknown Origin by DR KD DELE
Pyrexia (Fever) of Unknown Origin by DR KD DELEPyrexia (Fever) of Unknown Origin by DR KD DELE
Pyrexia (Fever) of Unknown Origin by DR KD DELE
 
Probable dengue
Probable dengueProbable dengue
Probable dengue
 
Pyrexia of unknown origin (puo)
Pyrexia of unknown origin (puo)Pyrexia of unknown origin (puo)
Pyrexia of unknown origin (puo)
 
Fever-DD&management
Fever-DD&managementFever-DD&management
Fever-DD&management
 
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
Pyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed HussienPyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed Hussien
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
PUO
PUOPUO
PUO
 
Adult Onset Still's Disease
 Adult Onset Still's Disease Adult Onset Still's Disease
Adult Onset Still's Disease
 
Fever of Unknown Origin
Fever of Unknown OriginFever of Unknown Origin
Fever of Unknown Origin
 
Fever unknown Origin
Fever unknown OriginFever unknown Origin
Fever unknown Origin
 
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
 
Janudice
JanudiceJanudice
Janudice
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACHFEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
FEVER OF UNKNOWN ORIGIN (PUO)- APPROACH
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
Protocol for fever
Protocol for feverProtocol for fever
Protocol for fever
 
Fever of unknown origin
Fever of unknown originFever of unknown origin
Fever of unknown origin
 
Evaluation of puo
Evaluation of puoEvaluation of puo
Evaluation of puo
 

Similar to Leptospirosis in child in mumbai

Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Ankit Raiyani
 
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECTLEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
KrithikaSambandam
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case managementBng Crz
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Marianne Somera
 
Leptospirosis case presentation
Leptospirosis case presentationLeptospirosis case presentation
Leptospirosis case presentation
DR MUKESH SAH
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
shabeel pn
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
Vishwa Jayasinghe
 
Neonatal sepsis tharindu n gunasiri
Neonatal sepsis   tharindu n gunasiriNeonatal sepsis   tharindu n gunasiri
Neonatal sepsis tharindu n gunasiri
Tharindu Nayanagith Gunasiri
 
INTERNAL-MEDICINE.pptx
INTERNAL-MEDICINE.pptxINTERNAL-MEDICINE.pptx
INTERNAL-MEDICINE.pptx
metchisulat
 
Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)
Lokanath Reddy Mummadi
 
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdfNephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
Arun170190
 
Typhoid-Fever.pptx
Typhoid-Fever.pptxTyphoid-Fever.pptx
Typhoid-Fever.pptx
RameshvarDhanure1
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
DJ CrissCross
 
Management of dengue fever in adults-compressed.pdf
Management of dengue fever in adults-compressed.pdfManagement of dengue fever in adults-compressed.pdf
Management of dengue fever in adults-compressed.pdf
kuhanKalaichelvan1
 
cerebral toxoplasmosis
cerebral toxoplasmosiscerebral toxoplasmosis
cerebral toxoplasmosis
Mehakinder Singh
 
Duty report er 29th 2015
Duty report er 29th 2015Duty report er 29th 2015
Duty report er 29th 2015Soroy Lardo
 
Abdominal Pain with Choledecolhitasis
Abdominal Pain with CholedecolhitasisAbdominal Pain with Choledecolhitasis
Abdominal Pain with Choledecolhitasis
soroylardo1
 
Dengue fever
Dengue feverDengue fever
lecture notes
lecture noteslecture notes
lecture notes
john522129
 

Similar to Leptospirosis in child in mumbai (20)

Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECTLEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Leptospirosis case presentation
Leptospirosis case presentationLeptospirosis case presentation
Leptospirosis case presentation
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
 
Neonatal sepsis tharindu n gunasiri
Neonatal sepsis   tharindu n gunasiriNeonatal sepsis   tharindu n gunasiri
Neonatal sepsis tharindu n gunasiri
 
INTERNAL-MEDICINE.pptx
INTERNAL-MEDICINE.pptxINTERNAL-MEDICINE.pptx
INTERNAL-MEDICINE.pptx
 
Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)
 
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdfNephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
Nephritic vs nephrotic syndrome6npoqoa8qakc (1).pdf
 
Typhoid-Fever.pptx
Typhoid-Fever.pptxTyphoid-Fever.pptx
Typhoid-Fever.pptx
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
 
Management of dengue fever in adults-compressed.pdf
Management of dengue fever in adults-compressed.pdfManagement of dengue fever in adults-compressed.pdf
Management of dengue fever in adults-compressed.pdf
 
cerebral toxoplasmosis
cerebral toxoplasmosiscerebral toxoplasmosis
cerebral toxoplasmosis
 
Duty report er 29th 2015
Duty report er 29th 2015Duty report er 29th 2015
Duty report er 29th 2015
 
Abdominal Pain with Choledecolhitasis
Abdominal Pain with CholedecolhitasisAbdominal Pain with Choledecolhitasis
Abdominal Pain with Choledecolhitasis
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
lecture notes
lecture noteslecture notes
lecture notes
 
Unusual cause of Renal failure
Unusual cause of Renal failureUnusual cause of Renal failure
Unusual cause of Renal failure
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

Leptospirosis in child in mumbai

  • 1. Dr. Chetan Chaudhari DNB Resident Department of Paediatrics HINDUHRIDAYSAMRAT BALASAHEB THACKERAY MEDICAL COLLEGE (HBTMC) & DR.R.N.COOPER MUNICIPAL GENERAL HOSPITAL, MUMBAI Date- 28st October 2020
  • 2.  On 31st July 2020  Roshani Gupta, 11 yrs old Female Child  Admitted at Dr.R.N.Cooper Hospital for the first time  Brought by : Mother (Informant Reliable)  Chief complaints: Fever since 4 days Body ache, Headache since 3 days Abdominal pain since 3 days Decreased oral intake since 3 days Difficulty in breathing since 1 day Clinical Scenario  Short History
  • 3.  Fever - 4 Days back, undocumented fever, insidious onset, mod-high grade, intermittent, no diurnal variations, relieved on oral medications. No chills or rigors. Normal inter febrile. followed by myalgia, Headache  Next day- persistence of above complaints + Abdominal pain, Decreased oral intake Decreased Urine Output  Difficulty in breathing – 1 Day prior, fast and labored breathing, progressive  Relevant H/O wading in rain water a week ago,  Normal Birth History, completely immunized, developmentally Normal, averagely built well nourished child History of present illness 
  • 4. DOA 1 Day 5 illness Conscious, Alert, GCS 15, in cardiorespiratory distress with vitals: • Temp: 37 C HR: 120 bpm RR: 60 bpm • SPO2: 90% off O2 BP: 110/70 mmHg (50th-90th) RS: • Tachypnea+, Symmetrical expansion • B/L AE reduced, B/L crepts + • +Intercostal retraction + Subcostal retraction • no local tenderness, • On O2 CPAP 96% with +RD +WOB Course in Ward  On Examination
  • 5. • CVS: Normal precordium, Apex beat at left 5th ICS MCL, (-) murmur, Tachycardia+ (-) thrills, (-) palpable P2; normally split S2; • Abdo: no scars, soft, no guarding/rigidity bowel sounds present, Liver non palpable, span 8 cm, Non tender Course in Ward  On Examination CNS: Conscious, oriented, follows commands GCS 15 (E4V5M6) Rest neurologic exam were unremarkable
  • 6. By 6 Hours of Admission • Diagnostics sent: ABG, CBC with DLC, PS, RMAT, CRP, BUN, S.Creat, S. Electrolytes, AST, ALT, PT APTT, blood CS, U/RM, Dengue test, Leptospira test, CXR PA, Covid-19 swab • Tachypnea+, ++ WOB, Significant distress with impending Respiratory failure, • ARDS • Hypotensive • Intubated, inotropes added, Upgraded AB • Pt. was Transferred to PICU Course in Ward  Under Evaluation
  • 7. Any thoughts ?? Any Questions ?? 
  • 8.
  • 9. Any thoughts ?? Lab Reports!!  • Lepto IgM + Lepto ELISA + • HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35 • BUN-17.8, Creat-0.9, SGOT-50,SGPT-36 • Na+135, K+3.8, Cl-99 • ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4 DOA 1 Day 5 illness
  • 10. Any thoughts ?? Lab Reports!!  • Lepto IgM + Lepto ELISA + • HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35 • BUN-17.8, Creat-0.9, SGOT-50,SGPT-36 • Na+135, K+3.8, Cl-99 • ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4 DOA 1 Day 5 illness By 4-5 Days of Admission On Mech. Ventilation, Over next few days Child had developed Oligouria, U/O ~ 0.7ml/kg/hr, Profuse pulmonary bleed, High grade Fever, continued RD+ GCS – 11/15
  • 11. Any thoughts ?? Lab Reports!!  • HB- 5.7, TLC- 22400, PLT- 81000, INR- 2.38 • BUN-112, Creat- 4.9, SGOT-7210,SGPT-4894 • Na+ 158, K+ 4.3, Cl-120 • MRI Brain- fronto-parietal micro haemorrhages, Chronic subdural hygroma By DOA 5 Day 10 illness
  • 12. Any thoughts ?? Lab Reports!!  • Lepto IgM + Lepto ELISA + • HB- 8.5, TLC- 8000, PLT- 91000, INR- 1.35 • BUN-17.8, Creat-0.9, SGOT-50,SGPT-36 • Na+135, K+3.8, Cl-99 • ABG-pH7.4, pO2-71 pCO2-29 HCO3-18.4 DOA 1 Day 5 illness • HB- 5.7, TLC- 22400, PLT- 81000, INR- 2.38 • BUN-112, Creat- 4.9, SGOT-7210,SGPT-4894 • Na+ 158, K+ 4.3, Cl-120 • MRI Brain- fronto-parietal micro haemorrhages, Chronic subdural hygroma By DOA 5 Day 10 illness
  • 13. Diagnosis  Leptospirosis with Multi Organ Dysfunction (ARDS with Pulmonary hemorrhage with Acute Liver Failure, Acute Kidney Failure, Hypernatremia) with Multiple intracranial hemorrhages with Bed sores treated for above diagnosis (3 PRBC, 3FFP, 3PLT, Inotropes, IV Steroids, Higher Antibiotics, Antifungal, Sedation, Antiepileptic, Neurotropic Proteins) 25 Days of Hospitalization
  • 14. Dr. Chetan Chaudhari DNB Resident Department of Paediatrics HINDUHRIDAYSAMRAT BALASAHEB THACKERAY MEDICAL COLLEGE (HBTMC) & DR.R.N.COOPER MUNICIPAL GENERAL HOSPITAL, MUMBAI Overview
  • 15.  Common & widespread zoonotic disease in the world in tropical and subtropical countries  Historically known as Weil’sdisease (Described in 1885 by Adolf Weil)  One of the emerging infectious diseases since the late 1990s Recent large outbreaks in Asia, Central & South America  Hosts - rats, dogs, cattle and pigs. Reservoir: rodents  Leptospires survive for days to weeks in water and moist soil  Transmission: Exposure to water or soil contaminated with rat urine Exposure to contaminated floodwaters High-risk occupations EPIDEMIOLOGY 
  • 16.  Patterns of transmission Epidemic / Endemic / Sporadic  In India, only sporadic cases being recorded.  Urban leptospirosis - reported from Mumbai & Chennai Last Outbreak reported was in Mumbai in 2015  Rural leptospirosis - Gujarat, Kerala & Andaman  Leptospirosis is endemic in  Kerala  Tamil Nadu  Gujarat  Karnataka  Maharashtra  Annual incidence (WHO) – 0.1 to 1 per 100 000 per year  Estimated case-fatality rates ranges from <5% - 30%
  • 17.  SpirocheteLeptospira – 22 species, 10 pathogenic species L. interrogans, L.icterohaemorrhagiae, L.copenhageni  All species are morphologicallyidentical Obligate Aerobic Motile Tightly & regularly coiled, MORPHOLOGY  Electron Microscopy
  • 18.
  • 19. Infects mucosa (oral, nasal or conjunctival) or through abraded skin or ingestion of contaminated water Proliferate in bloodstream and disseminate hematogenously Development of antibodies(5-7 days) Organisms disappear from blood & CSF but remain localized in tissues, organs including kidneys, brain, liver, lung, heart Pathogenesis
  • 20. Loss of fluids into the third space Hypovolaemic shock and vascular collapse Vascular Endothelial damage - produces endotoxin Attach onto the endothelial cells Capillary endothelial necrosis and lymphocytic infiltration Vasculitis and leakage : petechiae, intra parenchymal bleeding and bleeding along serosa and mucosa
  • 21. Excreted in urine Interstitial Nephiritis, Tubular Injury Penetrate basement membrane of PCT Adhere to proximal tubule epithelial cells Traverse interstitial spaces of kidney
  • 22. Brain – Aseptic meningitis, meningoencephalitis Eyes - Uveitis Lungs – involvement due to hemorrhage (not inflammation) Liver – Centrilobular Necrosis(usually not extensive) Cholecystitis, Pancreatitis Heart – Myocarditis, Skeletal Muscles – necrosis
  • 23.  Incubation period - 2 to 30 days (mean: 15 days)  Spectrum of disease - Asymptomatic (90%) Severe disease - (10%) with MODS & Death  Onset is abrupt & follows classically described biphasic course  Initial or Septicemic phase : 3-7 days leptospira in blood, CSF  Immune or leptospiruric phase : leptospira in urine appearance of circulating IgM antibody, disappearance of organisms from the blood and CSF signs and symptoms with localization of leptospira in tissues Clinical course 
  • 24. Clinical course & Clinical Menifestations
  • 25.  fever - Abrupt onset with flulike signs with shaking chills, lethargy, severe headache, malaise, generalized lymphadenopathy  Myalgia - severe debilitating myalgia most prominent in the lower extremities, lumbosacral spine, and abdomen (increase in Sr CPK level)  Cunjunctival suffusion ( but no chemosis and purulent exudate)  Rash - transient (<24 hr) erythematous maculopapular, urticarial, petechial, purpuric or desquamating rash  Aseptic meningitis - Immune phase (80% of infected children -abnormal CSF profiles, only 50% - clinical meningeal manifestations) pleocytosis with polymorphonuclear leukocytosis, normal or slightly elevated protein levels, and normal glucose CNS symptoms resolve spontaneously within 1 wk  Uveitis selflimited - unilateral or bilateral Anicteric Leptospirosis
  • 27.  Weil syndrome is a severe Severe form of leptospirosis more common in adults (>30 yr)  characterized by jaundice  Initial phase manifestations are similar to anicteric leptospirosis  Immune phase - Jaundice, Acute renal dysfunction & Thrombocytopenia  Fulminant cases – menifest with Pulmonary hemorrhage (morecommonly) Cardiovascular collapse Hepatic involvement Renal dysfunction Multisystem involvementoccurs Icteric Leptospirosis (Weil’s Syndrome)
  • 28.  Jaundice 4 - 7 day (direct & indirect hyperbilirubinemia)  right upper quadrant pain, tender hepatomegaly  modestly elevated serum levels of hepatic enzymes (<5 times the upper limit)  cholestasis with hepatocellular necrosis  Liver function usually returns to normal after recovery  Hepatic encephalopathy or death due to hepatic failure is rare  Splenomegaly in a minority of patients Hepatic involvement 
  • 29.  Acute kidney failure occurs in 16–40% of cases (most severe complication)  can occur after several days of illness (by 4th day or by 2nd wk)  Urine analysis - hematuria, pyuria, proteinuria  nonoliguric with K+ wasting, but may become oliguric  acute tubular necrosis (ATN) and interstitial nephritis  Azotemia - features of uremia like breathlessness, convulsion, delirium and altered level of consciousness in very severe cases  Severe acute failure cases- may require vasopressor support and hemodialysis, complete recovery occurs by the end of the 4th week, usually no residual renal dysfunction Renal involvement 
  • 30. Immunohistochemical demonstration of leptospira in kidney tissue
  • 31.  Mild illness - only cough, chest pain and blood tinged sputum  Severe cases - hemoptysis, rapidly increasing breathlessness which may lead to respiratory failure and death.  toxin-mediated capillary vasculitis OR immune mediated Capillary injury in the lungs >> leakage >> inflammatory reaction Pulmonary oedema >> fibrin depositions and proliferative fibroblastic reactions >> intra-alveolar haemorrhage >> acute respiratory distress syndrome (ARDS) Severe Pulmonary Form of Leptospirosis (SPFL) – intra-alveolar haemorrhage >> acute respiratory failure >> death  Death - within hours to 2 days due to pulmonary hemorrhage and severe respiratory distress.  Pulmonary haemorrhage syndrome >50% mortality rate Pulmonary involvement 
  • 32.  Hemorrhagic pneumonitis with interstitial and intra alveolar hemorrhage surrounded by focal capillary injury are common pathologic changes.  O/E – Tachypnea, crepitation in the basal region, which rapidly spread upwards to middle and upper lobes. Pulmonary involvement  Alveolar infiltrates are visible on CXR (basal and mid zone)
  • 33.  Abnormal ECG in 90% of cases. but congestive heart failure is uncommon  Myocarditis - Segmental depression and T wave inversion may be present in some patients.  Shock – Echocardiography reveals normal systolic function of left ventricle hypotension is due to either dehydration or peripheral vasodilatation  Arrhythmias - palpitations, syncope and irregular pulse. Supraventricular tachyarrhythmia A.V. blocks of various degrees Ventricular tachycardia infrequently Cardiovascular system involvement 
  • 34.  CNS - commonly present as meningitis. Aseptic Meningitis Headache, irritability, seizures & coma can occur. Encephalitis, focal deficits, spasticity, paralysis, nystagmus, peripheral neuropathies, nerve palsies  Transient thrombocytopenia in >50% of cases. Rarely, hemorrhagic manifestations occur, epistaxis, hemoptysis gastrointestinal, and adrenal hemorrhage bleeding manifestations in leptospirosis resolve in 2-3 days  Anterior uveal tract inflammation - Uveitis , iridocyclitis & rarely chorioretinitis Other Menifestations 
  • 35.  Suspected: Acute febrile illness with headache, myalgia and prostration associated with a history of exposure to infected animals or an environment contaminated with animal urine with one or more of the following – Calf muscle tenderness Conjunctival suffusion Anuria or oliguria and/or proteinuria Jaundice Hemorrhagic manifestations (intestines, lung) Meningeal irritation Nausea, Vomiting, Abdominal pain, Diarrhoea.  Probable: Suspected case with positive presumptive laboratory diagnosis.  Confirmed: Suspect/Probable case with confirmatory laboratory test. Recommended case definition 
  • 36. Presumptive diagnosis  A positive result in IgM based immune assays, slide agglutination test or latex agglutination test or immuno-chromatographic test.  A Microscopic Agglutination Test (MAT) titre of 100/200/400 or above in single sample based on endemicity.  Demonstration of leptospires directly or by staining methods Confirmatory diagnosis  Isolation of leptospires from clinical specimen  Four fold or greater rise in the MAT titer between acute and convalescent phase serum specimens run in parallel.  Positive by any two different type of rapid test.  PCR test. Criteria for Diagnosis 
  • 37.  High index of suspicion - exposure history & manifestations  “In endemic area all cases of fever with myalgia and conjunctival suffusion should be considered as suspected cases of leptospirosis.”  Biochemical, hematological and urinalysis may suggest but are not specific for diagnosis  The disease is usually diagnosed by – Serological tests – MAT Molecular- DNA PCR Rapid tests – ELISA Latex agglutination test Dipstick tests ( Lepto dipstick, Lepto Tek) Lepto Tek, Dri-Dot test Indirect hemagglutination Macroscopic slide agglutination test (MSAT) Diagnosis 
  • 38. Gold standard diagnostic method is the Microscopic Agglutination Test  Rapid tests - simple, more sensitive and become positive earlier than MAT (5-6th day) as they detect specific IgM antibodies  Culture - Leptospires can be cultured from blood and CSF during first 7-10 days, but takes 2-4 weeks to bepositive
  • 39. Dark field microscopy showing Leptospira spp.
  • 40. Microscopic Agglutination Test(MAT)  Sensitivity 92% Specificity 95%  MAT has a very limited availability  Negative in the first 7–10 days of onset on infection
  • 41.
  • 42. Treatment  Prompt initiation of antibiotic therapy shortens the course and prevents progression.  Prompt triage of High risk patients & early supportive T/t  Mild leptospirosis resolves without any treatment.  Severe disease - empirically broad- spectrum antibiotics before confirmation  Hypotension to be managed by fluids and vasopressors  Transfusion of blood and blood products  Specific Treatment of various organ system failure – Cardiovascular Pulmonary Renal Hepatic
  • 43.  Mild disease - Oral Doxycycline, Amoxicillin, and Ampicillin  Penicillin G (Inj. Crystalline penicillin 2–4 lacs IU/kg/day divided every 4-6 hr IV for 7 days)  Doxycycline (in children ≥8 yr of age) a short (<2 wk) course of doxycycline may be safe in children >2 yr of age Doxycycline 2 mg/kg/day divided in 2 doses (max 100 mg twice daily)  Cefotaxime, Ceftriaxone, and Azithromycin have demonstrated equivalent effectiveness with doxycycline Children< 8 years:  Amoxycillin/ Ampicillin 30-50 mg/kg/day in divided doses for 7 days  Inj. Crystalline penicillin 2–4 lacs IU/kg/ day for 7 days.  Ceftriaxone 50-75 IV mg/kg/day for 7 days  Cefotaxime 50-100 IV mg/kg/day for 7 days  Erythromycin OR Azithromycin may be given Antibiotics 
  • 44.  Transfusion of blood and blood products  Intensive immunosuppression - IV methylprednisolone  IV Methylprednisone f/b oral prednisolone for 7 days (Dose: 1 gram methylprednisone IV for first 3 days f/b oral prednisolone 1 mg/kg for 7 days.) reduced the need for ventilator support Steroids effective if given within first 24 hours of onset of pulmonary symptoms  Timely initiation of mechanical ventilation with PEEP and high FiO2  Hypoxemia in leptospirosis with pulmonary hemorrhage - difficult to treat inspite of maximal mechanical ventilation.  ECMO - cardiopulmonary support minimizes the damage by mechanical ventilation requiring high FiO2, high tidal volumes and high airway pressures Specific T/t of Organ System Failure  Pulmonary hemorrhage
  • 45.  Management of fluids and electrolytes  Management of AKI - Diuretic therapy  Acute interstitial nephritis - short course corticosteroids  Renal replacement therapy  Indications for acute renal replacement therapy or dialysis - Uremic Symptoms encephalopathy Serum creatinine > 3mg/dL Severe hyperkalaemia unresponsive to traditional treatment Serum K > 5.5 meqs/L in an oliguric patient Severe volume overload ARDS, Pulmonary hemorrhage pH <7.2 Fluid overload  Hemodialysis is preferred over peritoneal dialysis Specific T/t of Organ System Failure  Renal Dysfunction & Renal Replacement Therapy
  • 46. Prognosis   High mortality in severe disease,  Pulmonary haemorrhage >50% mortality rate  Poor prognostic indicators - pulmonary involvement, elevated creatinine, oliguria and thrombocytopenia  Liver dysfunction has not been confirmed to be an independent risk factor for death  No permanent sequelae or progressive organ dysfunction after resolution “Patients with multiple organ involvement to be referred to tertiary care centre”
  • 47.  No vaccine availablecurrently 1. Personal protection General sanitation measures, Rodents Control Avoidance of swimming in contaminated places Avoid of direct and indirect human contact with animal urine Use rubber shoes and gloves in water logged areas 2. Chemoprophylaxis During the peak transmission season Doxycycline 200 mg, once a week, for six weeks (never to be extended for more than eight weeks) Alternative-Azithromycin 10 mg/kg single dose (max 500 mg) PREVENTION 
  • 48.  Adequate history of exposure is most important in diagnosis  Possibility of leptospirosis to be kept in d/d of icteric illness acute flulike febrile illnesses.  Prompt treatment can prevent life threatening complications  Dialysis for acute kidney injury (AKI) and ventilatory support for respiratory failure would definitely reduce mortality.  Health education, sanitation measures and awareness for prevention Take Home Message 